v3.26.3
Operating Segments - Schedule of Group’s CODM (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Disclosure of operating segments [line items]      
Total $ 284 $ 461  
Cost of revenues 72 101  
Research and development expenses 1,575 938  
Sales, marketing and distribution 326 491  
General and administrative expenses 3,198 2,109  
Other income, net (465)  
Company’s share of losses of company accounted for at equity, net 312  
Loss 6,051 9,412  
Segment assets 18,491   $ 7,622
Segment liabilities 7,220   2,475
Operating segments [member]      
Disclosure of operating segments [line items]      
External 284 461  
Total 284 461  
Cost of revenues 72 101  
Research and development expenses 1,575 938  
Sales, marketing and distribution 326 491  
General and administrative expenses 3,198 2,109  
Other income, net   (465)  
Segments’ operating loss 4,887 2,713  
Company’s share of losses of company accounted for at equity, net   312  
Loss on impairment of loans   5,973  
Finance expense, net 1,164 414  
Loss 6,051 9,412  
Drug Development [Member]      
Disclosure of operating segments [line items]      
Segment assets 6,736   6,224
Segment liabilities 4,732   2,213
Drug Development [Member] | Operating segments [member]      
Disclosure of operating segments [line items]      
External  
Total  
Cost of revenues  
Research and development expenses 1,559 938  
Sales, marketing and distribution  
General and administrative expenses 3,154 2,070  
Other income, net   (465)  
Segments’ operating loss 4,713 2,543  
Online Sales [Member]      
Disclosure of operating segments [line items]      
Segment assets 1,309   1,398
Segment liabilities 394   $ 262
Online Sales [Member] | Operating segments [member]      
Disclosure of operating segments [line items]      
External 284 461  
Total 284 461  
Cost of revenues 72 101  
Research and development expenses  
Sales, marketing and distribution 326 491  
General and administrative expenses 22 39  
Other income, net    
Segments’ operating loss 136 $ 170  
Quantum Technology [Member]      
Disclosure of operating segments [line items]      
Segment assets 10,446    
Segment liabilities 2,094    
Quantum Technology [Member] | Operating segments [member]      
Disclosure of operating segments [line items]      
External    
Total    
Cost of revenues    
Research and development expenses 16    
Sales, marketing and distribution    
General and administrative expenses 22    
Segments’ operating loss $ 38